AKYÜZLÜ, D. Et Al. 2022. Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder: Effect on craving, depression, anxiety and age onset of first use. EUROPEAN JOURNAL OF PHARMACOLOGY , vol.921 .

AKYÜZLÜ, D., Özkan-Kotiloğlu, S., Yalçın-Şahiner, Ş., Ağtaş-Ertan, E., & Özgür-İlhan, İ., (2022). Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder: Effect on craving, depression, anxiety and age onset of first use. EUROPEAN JOURNAL OF PHARMACOLOGY , vol.921.

AKYÜZLÜ, DİLEK Et Al. "Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder: Effect on craving, depression, anxiety and age onset of first use," EUROPEAN JOURNAL OF PHARMACOLOGY , vol.921, 2022

AKYÜZLÜ, DİLEK Et Al. "Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder: Effect on craving, depression, anxiety and age onset of first use." EUROPEAN JOURNAL OF PHARMACOLOGY , vol.921, 2022

AKYÜZLÜ, D. Et Al. (2022) . "Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder: Effect on craving, depression, anxiety and age onset of first use." EUROPEAN JOURNAL OF PHARMACOLOGY , vol.921.

@article{article, author={DİLEK AKYÜZLÜ Et Al. }, title={Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder: Effect on craving, depression, anxiety and age onset of first use}, journal={EUROPEAN JOURNAL OF PHARMACOLOGY}, year=2022}